Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inge Verbrugge

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Discovery|May 16, 2012
Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated deathInge Verbrugge, Ricky W Johnstone
Epigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael Bots
Frontiers in Oncology|November 17, 2016
Combination Approaches with Immune-Checkpoint Blockade in Cancer TherapyMaarten Swart, Inge Verbrugge, Joost B Beltman
Cell|December 25, 2010
SnapShot: Extrinsic apoptosis pathwaysInge Verbrugge, Ricky W Johnstone, Mark J Smyth
Clinical and Translational Radiation Oncology|June 25, 2020
Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model systemShuraila F Zerp, Zainab Bibi, Inge Verbrugge, et al.
Oncoimmunology|December 25, 2012
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesInge Verbrugge, Mara Galli, Mark J Smyth, et al.
International Journal of Molecular Sciences|December 22, 2016
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten<sup>LoxP/LoxP</sup>;Braf<sup>CA/+</sup> MiceMarcel A Deken, Ji-Ying Song, Jules Gadiot, et al.
The Journal of Clinical Investigation|February 13, 2024
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in miceElselien Frijlink, Douwe M T Bosma, Julia Busselaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Combining radiotherapy with APO010 in cancer treatmentInge Verbrugge, Esther H J Wissink, Rogier W Rooswinkel, et al.
The Journal of Biological Chemistry|January 10, 2013
Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1Bert van de Kooij, Inge Verbrugge, Evert de Vries, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Discovery|May 16, 2012
Regulating the TRAIL of destruction: how A20 protects glioblastomas from TRAIL-mediated deathInge Verbrugge, Ricky W Johnstone
Epigenomics|December 1, 2011
Promises and challenges of anticancer drugs that target the epigenomeInge Verbrugge, Ricky W Johnstone, Michael Bots
Frontiers in Oncology|November 17, 2016
Combination Approaches with Immune-Checkpoint Blockade in Cancer TherapyMaarten Swart, Inge Verbrugge, Joost B Beltman
Cell|December 25, 2010
SnapShot: Extrinsic apoptosis pathwaysInge Verbrugge, Ricky W Johnstone, Mark J Smyth
Clinical and Translational Radiation Oncology|June 25, 2020
Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model systemShuraila F Zerp, Zainab Bibi, Inge Verbrugge, et al.
Oncoimmunology|December 25, 2012
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesInge Verbrugge, Mara Galli, Mark J Smyth, et al.
International Journal of Molecular Sciences|December 22, 2016
Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten<sup>LoxP/LoxP</sup>;Braf<sup>CA/+</sup> MiceMarcel A Deken, Ji-Ying Song, Jules Gadiot, et al.
The Journal of Clinical Investigation|February 13, 2024
PD-1 or CTLA-4 blockade promotes CD86-driven Treg responses upon radiotherapy of lymphocyte-depleted cancer in miceElselien Frijlink, Douwe M T Bosma, Julia Busselaar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Combining radiotherapy with APO010 in cancer treatmentInge Verbrugge, Esther H J Wissink, Rogier W Rooswinkel, et al.
The Journal of Biological Chemistry|January 10, 2013
Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) receptor 1Bert van de Kooij, Inge Verbrugge, Evert de Vries, et al.
Pageof 3